Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial

Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial

Introduction: Randomized, controlled trials of molnupiravir in real-world use during the Omicron wave are scarce. The frequency of hospitalization and death is low, so further research is needed to confirm the virological efficacy of molnupiravir.Methods: A single-center, randomized, controlled clin...

Full description

Bibliographic Details
Main Authors: Yayun Liu, Shiyong Fan, Aijing Xu, Lingling Ge, Xinyu Wang, Xu Dong, Mingxiao Xu, Wenhan Fan, Wu Zhong, Xuesong Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Pharmacology
Subjects:
antiviral drugs
molnupiravir
severe acute respiratory syndrome coronavirus 2
Omicron variant
vaccine breakthrough infection
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1197671/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1197671/full

Similar Items